- Concept UI
- M0028927
- Registry Numbers
- 0
- Scope Note
- Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers.
- Terms
-
Vaccines, DNA
Preferred Term
Term UI
T057976
Date01/01/1999
LexicalTag
ACX
ThesaurusID
NLM (1997)
-
Recombinant DNA Vaccine
Term UI
T000998420
Date11/20/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
DNA Vaccine
Term UI
T000998421
Date11/20/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Naked DNA Vaccine
Term UI
T000998422
Date11/20/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Recombinant DNA Vaccines
Term UI
T057973
Date03/07/1996
LexicalTag
NON
ThesaurusID
NLM (1997)
-
Vaccines, Recombinant DNA
Term UI
T057974
Date03/07/1996
LexicalTag
NON
ThesaurusID
NLM (1997)
-
DNA Vaccines
Term UI
T057975
Date03/05/1996
LexicalTag
NON
ThesaurusID
NLM (1997)
-
Naked DNA Vaccines
Term UI
T057972
Date03/07/1996
LexicalTag
NON
ThesaurusID
NLM (1997)